Price
Frequently asked questions
What is ICON's market capitalization?
What is ICON's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for ICON?
What are the analyst ratings and target price for ICON's stock?
What is ICON's revenue over the trailing twelve months?
What is the EBITDA for ICON?
What is the free cash flow of ICON?
What is the 5-year beta of ICON's stock?
How many employees does ICON have, and what sector and industry does it belong to?
What is the free float of ICON's shares?
Financials
Market Cap
$17.52B5Y beta
1.21EPS (TTM)
$8.994Free Float
81.99MP/E ratio (TTM)
23.59Revenue (TTM)
$8.31BEBITDA (TTM)
$1.69BFree Cashflow (TTM)
$1.23BPricing
Analyst Ratings
The price target is $365.40 and the stock is covered by 16 analysts.
Buy
15
Hold
1
Sell
0
Information
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
42,250
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker